Clinical Trial

Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System in Mexico

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical research study is to evaluate the feasibility / performance, safety and initial efficacy of the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System (MAGNET System, DI Biofragmentable) for creation of a side-to-side anastomosis duodeno-ileostomy in obese adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-18.
Trial Details
NCT Number NCT07085741
Lead Sponsor GT Metabolic Solutions, Inc.
Conditions Obesity, Type 2 Diabetes
Enrollment 10 participants
Start Date 2025-05-07
Primary Completion 2025-10-19 (estimated)
Study Completion 2026-07-16 (estimated)
Updated on ClinicalTrials.gov 2025-12-23